Polymorphonuclear neutrophils (PMN) traverse basement membrane to reach sites of infection. We have studied the role of laminin, a specific basement membrane component, in this process using three assay systems. In the Boyden chamber, laminin was found to stimulate chemotaxis of neutrophils while fibronectin did not. Co-incubation of cells with antibody to laminin blocked this chemotaxis, while antibody to fibronectin was without effect. In the human amnion system, neutrophils were shown to penetrate through the tissue when the peptide chemoattractant f-Met-Leu-Phe was placed on the opposing side. Antibody to laminin, but not to fibronectin, blocked this penetration. In an attachment assay system, laminin, but not fibronectin, was found to increase dispase-treated neutrophil attachment to type IV (basement membrane) collagen-coated plastic and to a plastic substrate itself. Electrophoretic analysis of PMN extract indicated the presence of laminin, and indirect immunofluorescence suggested that laminin is localized on the surface of the neutrophils. These data suggest that PMN can bind laminin on their cell surfaces, use laminin to attach to basement (type IV) membrane collagen, and migrate toward a gradient of laminin. These properties may be important for the passage of neutrophils from the circulation to sites of infection.
Introduction
Chemotactic behavior is a property of a variety of cells engaged in such biological processes as wound repair, development, neurite outgrowth, tumor invasion, and inflammation (1) . In the inflammatory response the initial interaction between polymorphonuclear neutrophils (PMN)' and the endothelial basement membrane is one ofthe critical events for PMN migration from blood vessels to sites of infection. Presumably, chemotactic stimuli released at the site of inflammation initiate the migration of these cells from the circulation (2) . Phagocytic cells have been shown to respond to well-defined chemotactic factors such as formylated peptides (3) as well as to many other substances (1) . PMN contain enzymes capable of degrading basement mem-brane components, allowing them to move through this barrier (4) . Little, however, is known about how PMN bind to the basement membrane and to other extracellular matrices through which they must move. Adherence of PMN to components of the extracellular matrix appears to be important, since these cells normally require a substrate to migrate (2) .
Recently, PMN have been reported to adhere to a greater extent to cultured endothelial cells than to monolayers of other cell types (5) . Chemoattractants such as f-Met-Leu-Phe have been shown to stimulate this adherence (5) , and the role of extracellular matrix components has also been investigated. Fibronectin, a large glycoprotein found in serum and in fibrous connective tissue (6, 7) , has been implicated in PMN adherence to collagenous substrates (8) . Laminin (Mr -106), a large and abundant basement membrane-specific glycoprotein, binds to type IV collagen, to heparan sulfate proteoglycan, and to an integral membrane protein on the surface of certain epithelial and neoplastic cells (9) (10) (11) (12) (13) (14) . It also has been shown to alter the shape of certain cells and to promote matrix deposition (15) (16) (17) . Furthermore, laminin promotes the haptotactic migration ofmurine B 16 melanoma cells (18) . We have examined the possibility that PMN, which must penetrate the basement membrane on their way to sites of infection, use laminin as an attractant and an attachment factor.
Methods
Preparation ofsubstrates and antibodies. Type I collagen was prepared from lathyritic rat skin ( 19) ; type II collagen from a rat chondrosarcoma (20); type III collagen from fetal calf skin (21) ; and type IV collagen from the Engelbreth-Holm-Swarm tumor (10) . The various collagens were dissolved in 0.5 M acetic acid and diluted to a concentration of 2 gg/ml with 0.1 M acetic acid. An aliquot (1 ml) of the collagen solution was then added to each well of a Linbro tissue culture tray and allowed to dry for 48 h under ultraviolet light.
Laminin was purified as previously described (9, 10) and coated on Linbro tissue culture trays as described for the collagens. Briefly, laminin was purified as follows: the protein was extracted from Engelbreth-HolmSwarm mouse tumor with 0.5 M NaCl. The extract was chromatographed twice using DEAE cellulose, and then passed over an ASM agarose column (1 1). The laminin obtained showed only the two expected bands (200,000 and 400,000 mol wt) when subjected to gel electrophoresis under reducing conditions. The laminin obtained from the A5M agarose column was then passed over a Bio-Gel-P-I0 polyacrylamide gel filtration column to ensure its separation from low molecular weight contaminants. Fibronectin was prepared from rabbit serum as previously described (22) and coated on Linbro tissue culture trays as described above for the other proteins. Antibodies to laminin and fibronectin were raised in rabbits as described previously (10) , and their specificities were confirmed by immunoprecipitation and Western blot analysis. Antibody to human PMN was raised in rabbits. Cells from 15 different donors were suspended in Freund's adjuvant and injected intramuscularly in rabbits. The sera containing antibodies obtained from this procedure were gifts from Dr. Steven Buscher, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The concentrations of affinity-purified antibodies were adjusted to 100 Atg/ml of protein and of the serum containing antileukocyte antibody to 1 mg/ml of protein.
Attachment assay. The attachment assay was adapted from that described by Terranova et al. (11) with the following modifications. In preliminary experiments, it was found that neutrophils adhered rapidly and completely to a variety of surfaces (Table I) . Therefore, where indicated, the cells were pretreated with proteases to destroy cell-associated attachment factors. PMN were preincubated in a Hepes-buffered isotonic salt solution lacking divalent cations and containing 100 ug/ml of collagenase-dispase (Boehringer Mannheim Biochemicals, Indianapolis, IN) for 30 min at 370C. Protease-treated cells were then incubated for 2 h at 370C in Gey's balanced salt solution (GBSS) containing 2% bovine serum albumin (BSA). This was done to allow time for resynthesis of membrane components. In other experiments, protease-treated and untreated PMN were preincubated with Eagle's minimum essential medium plys cycloheximide (25 ug/ml), chloramphenicol (10 (23) . The data are expressed as the percent total cellular content of the various constituents, determined from the lysate from three freeze-thaw cycles carried out in the presence of 0.1% Triton X-100 (Rohm and Haas Co., Philadelphia, PA).
Chemotaxis assay. Chemotaxis was assayed in the modified Boyden chamber as previously described (1, 3) . Rabbit peritoneal exudate cells induced by 0.2% glycogen injection were obtained by peritoneal lavage using heparinized saline. The suspension of cells were centrifuged at 1,000 rpm, 25°C for 10 min. The pelleted cells were washed twice in heparinized saline and resuspended in GBSS (3). Rabbit neutrophils obtained in this manner (3) were suspended at a concentration of2.2 X 106 cells/ml and placed in the upper compartment of the Boyden chaflber.
The lower compartment, which contained the chemoattractant, was separated from the upper compartment by a Millipore cellulose nitrate microporous filter (pore diameter 5 Mm). After 2 h of incubation at 37°C, filters were removed, washed, stained with hematoxylin, and mounted bottom side up on glass slides. 10 high power fields (HPF) (X 400) were counted to determine the number of cells that had migrated entirely across the IO0-Am width ofthe filter. Negative controls were the number of cells that had migrated in the absence of an attractant. In all cases for values greater or equal to 5 cells/HPF, the SEM did not exceed 10%. Cells used in motility studies were not treated with protease, since this markedly decreased motility. Trypan blue dye exclusion test was used to assess viability of cells that had migrated through the filters. Greater than 99% of the migrated cells had maintained viability after a 2-h chemotaxis assay.
Amnion penetration assay. Human amnions obtained fresh from normal term placentas were rinsed three times in 0.02 M NaPO4, pH 7.4, which contained 0.15 M NaCI and 0.02% sodium hypochlorite (24) . Amnions were then washed three times with phosphate-buffered saline (PBS) containing penicillin (100 U/ml), streptomycin (100 Mg/ml), and amphotericin B (1 ig/ml). Amnions were immersed in Eagle's minimal essential media supplemented with glutamine (4 mM), penicillin (100 U/ml), and streptomycin (100 ,g/ml). The intact amnion was stretched between the two rings of an amnion chamber (24) Millipore filter was placed in the chamber attached to the stromal surface of the amnion and facing the lower compartment of the chamber. The chambers were placed in 6-well cluster dishes (Costar, Cambridge, MA) containing GBSS with 2% BSA.
Rabbit PMN (2.2 X 10), which in some cases were preincubated with the antibodies at 370C for 2 h, were introduced into the upper compartment of the amnion chamber. F-Met-Leu-Phe (10-8 M) was used as the chemoattractant in the lower compartment. After 8 h of incubation at 370C, PMN which had traversed the full thickness of the amnion onto the filter were quantitated after hematoxylin staining of the Millipore filters. Six HPF (X 900) were used to quantitate the total number of PMN on each filter. The results of each experiment are expressed as the average of triplicate assays.
Indirect immunofluorescence. Indirect immunofluorescence was used to test the reaction of affinity-purified antibodies diected against laminin and fibronectin with the cells not treated with protease. Briefly, 2.2 X 106 cells/ml were incubated in GBSS with 2% BSA to inhibit nonspecific fluorescence. Aliquots (0.1 ml) were then smeared and air dried on gelatincoated glass slides that had been previously cleaned in absolute ethanol and flamed. Slides were incubated in a humidifed chamber at 220C with sheep anti-laminin, sheep anti-fibronectin, and preimmune sheep sera (negative controls). The second antibody was fluorescein-conjugated goat anti-sheep IgG (N.L. Cappel Laboratories, Inc., Cochranville, PA). Both the anti-laminin and anti-fibronectin antibodies were used at a dilution of 1:256.
Immunoprecipitation. Affinity-purified rabbit antibody to laminin was prepared as described previously (10) . Rabbit PMN were homogenized in a ground glass homogenizer and extracted for laminin (12) .
Affinity-purified rabbit antibody to laminin and extracts of PMN were mixed in ratios of 1:100, 1:250, and 1:500, and incubated at 370C for 2 h. The resulting mixtures were centrifuged at 20,000 rpm for 2 h. The immunoprecipitate obtained was subsequently analyzed using 5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and stained with Coomassie Blue.
Results
Laminin stimulates PMN motility. Since connective tissue proteins such as fibronectin and laminin have been shown to stimulate motility in various cells (18, 25, 26) , we tested the effects of both of these proteins upon PMN motility. Laminin, at a concentration of 2.5 ,ug/ml, produced a half-maximal migratory response by cells in the Boyden chamber assay that was equivalent to that produced by 5 X IO-10 M f-Met-Leu-Phe. Fibronectin produced a much smaller response (<10% of the maximal for f-Met-Leu-Phe) over the same range of concentrations tested for laminin (Fig. 1 exposed to a gradient of soluble laminin, since in a separate experiment using '251-radiolabeled laminin, -6% of the protein had diffused from the lower well to the upper well ofthe Boyden chamber in 1 h (data not shown).
The concentration of laminin was varied in the upper and lower wells of the Boyden chamber in a systematic fashion to test chemotaxis in the checkerboard assay (27) . In addition to an increasing chemokinetic motility as a function of laminin concentration (Fig. 2, data on the diagonal) , there was also a substantial chemotactic response. The numbers of cells that had migrated in positive gradients (below the diagonal) were substantially greater than those that had migrated in negative gradients (above the diagonal). These results indicate that laminin induces a true chemotactic response in PMN.
Addition of antibody to laminin to a maximally stimulating concentration of laminin (10 ,ug/ml) in the lower well of the Boyden chamber inhibited the chemotactic response in a dosedependent manner similar to its inhibition of cell attachment as shown in Fig. 7 . Antibody to fibronectin, however, had no effect upon the motility. These results suggest that laminin itself was responsible for stimulating motility in PMN.
We attempted to determine whether cell-associated laminin had a role in the development of a chemotactic response in PMN in general. Cells were treated with antibody to laminin (100 ,g/ml ofprotein) and were exposed to the attractant f-MetLeu-Phe at l1-0 M. The motile response was markedly reduced (Fig. 3) , whereas an antibody to fibronectin used at the same concentration ofprotein had little or no effect on migration (Fig.  3) . BSA (2%) or preimmune sheep serum were also without effect (data not shown). The results suggest that a form ofcell-associated laminin may be required for chemotaxis of PMN.
To determine whether the effect of the antibody to laminin upon motility was the result ofa nonspecific antibody interaction with PMN, we studied the effect of another antibody on PMN chemotaxis to f-Met-Leu-Phe. An anti-leukocyte antibody exhibited a dose-dependent inhibition of chemotaxis (Fig. 4) that was similar to the inhibition produced by antibody to laminin. However, unlike the antibody to laminin, low concentrations ofthe anti-leukocyte antibody appeared to stimulate cell motility in a dose-dependent manner (Fig. 4) etration was increased when (f-Met-Leu-Phe) 10-9 M was used as the attractant (5±4 cells for the negative control and 29±6 cells for laminin addition). We determined whether PMN would be inhibited by anti-laminin antibody from penetrating the amniotic membrane in response to the f-Met-Leu-Phe (1 X 10-8 M). Treatment of either the PMN or of the amnion matrix with anti-laminin antibody markedly inhibited penetration of PMN in a dose-dependent manner, whereas antibody to fibronectin had no appreciable effect (Fig. 5) . These data are similar to those observed in the Boyden chamber assay, where antibody to laminin inhibited chemotaxis to f-Met-Leu-Phe, but antibody to fibronectin did not (Fig. 3) . The data suggest that neutrophils can use laminin as opposed to fibronectin in traversing a matrix having a basement membrane similar to that of the vasculature.
Attachment ofPMN to various substrates. Rabbit PMN adhered rapidly and strongly to all substrates tested (Table 1) . Pretreatment of the cells with proteases reduced the adherence to plastic (100%) in 30 min to 17%. Greater adherence (38%) to dishes coated with type IV collagen or with laminin (95%) was observed (Table I) . Unlike epithelial cells (11), PMN adherence is unaffected by the presence of inhibitors of protein synthesis.
In the presence of 10 keg/ml puromycin, 25 ,g/ml cycloheximide and 25 ,gg/ml chloramphenicol PMN attach to laminin-coated dishes at 95% maximal levels. While protease treatment ofPMN may limit application of results with these cells to an in vivo situation, in this system it appears that laminin is much more effective than fibronectin in promoting PMN adherence.
Laminin as an attachmentfactorfor PMN. Since fibronectin has been shown to be an attachment factor for a variety of cells (6, 7, 28) , we compared the effects of fibronectin and laminin on the adherence of protease-treated PMN to type IV collagencoated dishes. Increasing concentrations of soluble laminin caused a progressively greater adherence of PMN. At a concentration of 10 ,g/ml of laminin, maximal adherence (100%) was observed. Fibronectin over the same range of concentrations had no effect on cell attachment (Fig. 6) .
The specificity of laminin over fibronectin is supported by the demonstration that antibody to laminin inhibited adherence of intact PMN to type IV collagen-coated dishes in a dose-dependent manner, whereas antibody to fibronectin did not (Fig.   7) . The inhibiting effect of the antibody to laminin was reversed by the addition of 10 tsg/ml of soluble laminin (Fig. 8) . Our results with the antibody to laminin do not appear to be a con-100 _ Figure 5 . Effect of affinity-purified antibody to laminin and fibronectin Fig. 4 ). In contrast, the antibody to laminin produced a markedly dose-dependent inhibition of adherence (82% at a 1:200 dilution). Additional evidence that PMN can use laminin as an attachment factor was obtained when proteolytically derived PI fragment of laminin (1 ig/ml), which retains the cellbinding site but not the collagen-binding site (13, 14) , totally inhibited attachment of PMN to type IV collagen or laminincoated dishes (Fig. 8) .
Effect of laminin upon PMN degranulation. Release of lysosomal components induced by certain agents including attractants such as f-Met-Leu-Phe accompanies the adherence and spreading of neutrophils in vitro (23) . We determined whether a concentration of laminin (1.0 Aeg/ml) that caused maximal adherence of PMN also affected secretion by these cells. Laminin caused significant release of the specific granule constituent vitamin B-12-binding protein (35±4% released in the presence of laminin vs. 13±6% released in buffer, P < 0.05). However, laminin had no detectable effect on the release of lysozyme (found in specific and primary azurophil granules), ofbeta glucuronidase (a primary granule marker), or of the cytoplasmic enzyme, lactic dehydrogenase. Therefore, laminin, in addition to enhancing the adherence of PMN by favoring binding of cells to type IV collagen, may also contribute to cell attachment by stimulating secretion ofspecific granules. The mechanism of this is not clear.
Laminin as a component of PMN. After attaching to the vascular wall, the migration of leukocytes through the endothelium seems to be a critical event. The migration could be accomplished by cells responding to an attractant, reversibly adhering to membrane components such as laminin and type IV collagen, and then moving through the matrix. This implies that some cells should contain laminin on their surface. The presence of laminin on these cells was shown by electrophoresis of an immunoprecipitate of an extract of PMN with antibody to laminin (Fig. 9) , and also by indirect immunofluorescence (Fig. 10) . The 400,000-and 200,000-mol-wt components seen on 5% sodium dodecyl sulfate-polyacrylamide gels under reducing conditions are characteristic of laminin, and are evident in correspondingly increasing amounts as a function of increasing quantities of the affinity-purified antibody used for immunoprecipitation. In addition, immunoprecipitation of rabbit peripheral PMN showed bands at 400,000 and 200,000 mol wt. diffuse fluorescence pattern similar to that produced by nonimmune serum (Fig. 10, B and C) . Furthermore, dispase-treated cells did not fluoresce, whereas peripheral PMN had punctate regions of high fluorescence (Fig. 10, D and E).
Discussion
We have shown that rabbit peritoneal exudate PMN contain laminin on their cell surface and can use laminin to bind to type IV collagen substrates. Furthermore, laminin was shown to be chemotactic for PMN. Fibronectin, however, was shown to have no effect on PMN adherence to isolated basement membrane components, nor to have chemotactic activity. These data suggest a mechanism for PMN passage through the endothelial basement membrane involving both the adherence ofthe cells by laminin to major components of this tissue, specifically to type IV collagen, and subsequent migration of cells in response to local pools of solubilized laminin. Low concentrations (1.0 ig/ml) of soluble laminin stimulated a half-maximal motility response in PMN not previously exposed to protease. This is equivalent to a molar concentration of 5 nM, indicating that laminin is a highly potent chemotactic agent, although less effective than the f-Met-Leu-Phe, with a half-maximal dose of 0.5 nM (1) . While the results with the checkerboard assay are consistent with laminin possessing true chemotactic properties, we cannot rule out a role for a chemotactic response to laminin that has been immobilized as shown for a Schwann cell line (26) and a murine melanoma cell line (18) . This "seeking" of adherence sites may not be the only mechanism by which the PMN respond to substrate-bound laminin. Laminin causes a significant release of specific granules, a phenomenon noted during the action ofcertain secretagogues and chemoattractants in promoting PMN adherence and spreading (23) . However, the biochemical nature of secretagogue-stimulated adherence is not understood. In this regard, it has been reported that endothelial cells bind chemotactic peptides for PMN, and that this partly accounts for the adherence of PMN to endothelial cell monolayers (5) . These effects of laminin were also demonstrable in the human amnion system. The finding that antibodies to laminin but not fibronectin inhibit PMN functions supports a role for laminin in PMN adherence and migration. Our studies have yielded different results from those reported by Giavazzi and Hart (29), who found that laminin inhibited attachment of both rodent macrophages and human peripheral PMN. As shown by the immunofluorescence study, it is likely that our protease-treated cells have lost a major portion of their cell surface laminin, and would therefore bind to laminin-coated surfaces, presumably through their cell-surface receptors for laminin. Any laminin remaining on the surface ofthe cell could then bind the cell to a type IV collagen-coated matrix. In the case of cells not treated with protease, antibody to laminin also inhibited attachment. This suggests that even for functioning of other attachment factors such as fibronectin, cell surface laminin may be a required component.
In vivo, as the cell becomes activated by diffusible inflammatory stimuli that penetrate the vasculature, the PMN may become a heterogenous group of cells with varying amounts of attachment factors, such as laminin, on their surfaces. As in the in vitro system, laminin-deficient PMN might use the laminin ofthe subendothelial basement membrane for their attachment, while the PMN with a laminin-rich cell membrane would bind to type IV collagen in the basement membrane.
The passage of PMN through basement membrane implies a reversible adherence of the cells to the matrix. Passage of the PMN would be facilitated by the release of proteases from PMN (cathepsins and collagenases) that degrade matrix components in the vicinity of the migrating cells (4) . The observation that laminin, a surface component of PMN, stimulates motility in these cells, has similarities to chemotactic behavior of other cells. Fibronectin, a prominent component of fibroblasts, stimulates chemotaxis of fibroblasts (25) . Cyclic AMP, an attractant for slime mold cells, is produced in large quantity by these cells (30). Finally, in the case of PMN themselves, it has been shown that chemotactic stimulation of these cells induced the production and release ofa potent leukoattractant, leukotriene B4, which may recruit still additional PMN (31, 32) . Note, however, that laminin has not yet been shown to be synthesized by PMN. Fibronectin, reported by others to enhance PMN attachment (8) , did not affect attachment of peritoneal cells in this study. It is conceivable that protease treatment may have appreciably removed both this protein and its attachment site on the cell surface. However, intact cells, upon being exposed to antibody to fibronectin, did not show any effect on the cell motility or attachment. On the other hand, intact cells treated with antibody to laminin showed marked reduction in both adherence and responsiveness to chemotactic stimuli. It is possible that exudate cells used in this study may have lost some of their surface components compared with peripheral PMN. This may reflect the differences of cell responsiveness to laminin and fibronectin. This suggests that laminin may be a more significant factor than fibronectin in the extravasation of PMN from the vasculature in response to inflammatory stimuli. Since laminin caused a significant amount of secretion from PMN, it may additionally enhance PMN adherence by this process.
However, since present evidence suggests that many different cell types, for example, hepatocytes (7), myoblasts (7) , and tumor cells (12) , have the ability to respond to different attachment factors, we would not exclude the possibility that PMN have the ability to use many other attachment proteins as they pass from the vasculature to sites of infection. This would not only appear biologically reasonable, but also necessary, since few basement membrane components are found in stromal tissues. Thus, the cells would attach to a complex substrate they encounter using a variety of cell surface receptors and attachment proteins. It is relevant to point out here that the cell, in moving through a three-dimensional matrix, may gain anchorage by mechanisms other than adhesion (33) , since in model systems the penetration of such matrix cells maintained a rounded morphology characteristic of nonadherent cells. Our findings support the concept that these cells can, as one of a variety of possible mechanisms, chemotactically respond to laminin, and can use laminin as an attachment factor during their emigration from the vasculature.
